h-header

news

News from the world

27

Jan

Tariff Uncertainty Drives Short-Term Manufacturing Surge as Global Pharmaceuticals Enter Fragmented Growth Phase

  • lobal pharmaceutical output surged in 2025 due to preemptive production ahead of U.S. tariff actions, with a 9.1% increase in manufacturing output.
  • The pharmaceutical sector benefits from structural resilience, stable demand, and strong credit conditions, supporting long-term investment despite economic uncertainties.....[PharmExec]

09

Mar

US FDA drafts guidance on best practices for responding to inspection observations

The US Food and Drug Administration (FDA) has released a draft guidance detailing how manufacturers should...

09

Mar

Intelligenza Artificiale e salute: le agenzie regolatorie al centro della rivoluzione farmaceutica

L’introduzione dell’Intelligenza Artificiale (IA) nella medicina e nella farmaceutica sta...

06

Mar

Testo unico Legislazione Farmaceutica,: assegnato alla X Commissione Senato

La V Commissione Bilancio del Senato della Repubblica ha espresso parere favorevole al disegno di legge...

04

Mar

ECHA’s Risk Assessment Committee adopts its opinion on PFAS restriction proposal

The European Chemicals Agency’s (ECHA) Risk Assessment Committee (RAC) has concluded its evaluation...

slider-banner

h-footer